Literature DB >> 8112468

'Camelising' human antibody fragments: NMR studies on VH domains.

J Davies1, L Riechmann.   

Abstract

A human heavy chain variable domain (VH) was expressed in bacteria for structural analysis by NMR spectroscopy. NMR analysis was initially impossible due to the short transverse proton relaxation time of the VH, probably caused by aggregation through the exposed interface naturally in contact with the light chain. The relaxation time was improved to normal values when this interface was mutated to mimic heavy chains of camel antibodies naturally devoid of light chains and through the use of the detergent CHAPS. Assignment of NMR signals will now be possible after isotopic labeling. Implications for the design of VH domains as minimum size immunoreagents are outlined.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8112468     DOI: 10.1016/0014-5793(94)80432-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  28 in total

1.  Single-domain antibody fragments with high conformational stability.

Authors:  Mireille Dumoulin; Katja Conrath; Annemie Van Meirhaeghe; Filip Meersman; Karel Heremans; Leon G J Frenken; Serge Muyldermans; Lode Wyns; Andre Matagne
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

Review 2.  Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins.

Authors:  David C Butler; Julie A McLear; Anne Messer
Journal:  Prog Neurobiol       Date:  2011-11-18       Impact factor: 11.685

3.  Structure of a low-melting-temperature anti-cholera toxin: llama V(H)H domain.

Authors:  Patricia M Legler; Dan Zabetakis; George P Anderson; Anita Lam; Wim G J Hol; Ellen R Goldman
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-01-26

4.  A new high molecular weight immunoglobulin class from the carcharhine shark: implications for the properties of the primordial immunoglobulin.

Authors:  R M Berstein; S F Schluter; S Shen; J J Marchalonis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

Review 5.  Engineered Autonomous Human Variable Domains.

Authors:  Johan Nilvebrant; Peter M Tessier; Sachdev S Sidhu
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

6.  Backbone assignment, secondary structure and protein A binding of an isolated, human antibody VH domain.

Authors:  L Riechmann; J Davies
Journal:  J Biomol NMR       Date:  1995-09       Impact factor: 2.835

7.  Solution properties of Escherichia coli-expressed VH domain of anti-neuraminidase antibody NC41.

Authors:  A A Kortt; R E Guthrie; M G Hinds; B E Power; N Ivancic; J B Caldwell; L C Gruen; R S Norton; P J Hudson
Journal:  J Protein Chem       Date:  1995-04

8.  Natural and man-made V-gene repertoires for antibody discovery.

Authors:  William J J Finlay; Juan C Almagro
Journal:  Front Immunol       Date:  2012-11-15       Impact factor: 7.561

9.  Cell penetrable humanized-VH/V(H)H that inhibit RNA dependent RNA polymerase (NS5B) of HCV.

Authors:  Kanyarat Thueng-in; Jeeraphong Thanongsaksrikul; Potjanee Srimanote; Kunan Bangphoomi; Ornnuthchar Poungpair; Santi Maneewatch; Kiattawee Choowongkomon; Wanpen Chaicumpa
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

10.  A case of convergence: why did a simple alternative to canonical antibodies arise in sharks and camels?

Authors:  Martin F Flajnik; Nick Deschacht; Serge Muyldermans
Journal:  PLoS Biol       Date:  2011-08-02       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.